FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

37912311000001106: Risedronate sodium 35mg tablets (Aristo Pharma Ltd) 4 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 25-Dec 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
585601000001115 Risedronate sodium 35mg tablets (Aristo Pharma Ltd) 4 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
585621000001110 Risedronate sodium 35mg tablets (Aristo Pharma Ltd) 4 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Risedronate sodium 35mg tablets (Aristo Pharma Ltd) 4 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Risedronate sodium 35mg tablets (Aristo Pharma Ltd) 4 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Risedronate sodium 35mg tablets (Aristo Pharma Ltd) 4 tablet Has AMP Risedronate sodium 35mg tablets (Aristo Pharma Ltd) true Inferred relationship Existential restriction modifier
Risedronate sodium 35mg tablets (Aristo Pharma Ltd) 4 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Risedronate sodium 35mg tablets (Aristo Pharma Ltd) 4 tablet Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Risedronate sodium 35mg tablets (Aristo Pharma Ltd) 4 tablet Is a Risedronate sodium 35mg tablets 4 tablet true Inferred relationship Existential restriction modifier
Risedronate sodium 35mg tablets (Aristo Pharma Ltd) 4 tablet Has excipient Lactose false Inferred relationship Existential restriction modifier
Risedronate sodium 35mg tablets (Aristo Pharma Ltd) 4 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Risedronate sodium 35mg tablets (Aristo Pharma Ltd) 4 tablet Has specific active ingredient Risedronate sodium true Inferred relationship Existential restriction modifier
Risedronate sodium 35mg tablets (Aristo Pharma Ltd) 4 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Risedronate sodium 35mg tablets (Aristo Pharma Ltd) 4 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Risedronate sodium 35mg tablets (Aristo Pharma Ltd) 4 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Risedronate sodium 35mg tablets (Aristo Pharma Ltd) 4 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start